Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
about
Prostate cancer screening practices and beliefsConditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerInsulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.Incidence, mortality and survival patterns of prostate cancer among residents in Singapore from 1968 to 2002Antibiotic and anti-inflammatory use and the risk of prostate cancerIntegration of prostate cancer clinical data using an ontology.Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results ProgramA networks method for ranking microRNA dysregulation in cancer.TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair systemTelomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancerA multilevel analysis of socioeconomic status and prostate cancer riskScreening for pancreatic cancer: why, how, and who?Socioeconomic disparities in the decline in invasive breast cancer incidence.Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and ConnecticutRaising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsyNovel diagnostic biomarkers for prostate cancer.Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses.A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.The value of current diagnostic tests in prostate cancer screening.Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011.High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.Sexual rehabilitation after localized prostate cancer: current interventions and future directions.The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.Prostate cancer incidence and mortality rates and trends in the United States and CanadaWatchful waiting as a treatment option for localized prostate cancer in the PSA era.Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.Environment as a potential key determinant of the continued increase of prostate cancer incidence in martinique.The role of alpha-blockers in the management of prostate cancerThe past, present, and future of cancer incidence in the United States: 1975 through 2020Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer.Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy.Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.Lower incidence of inguinal hernia: minilaparotomy radical retropubic prostatectomy compared with conventional technique. A preliminary report.Clinical significance of incidental FDG uptake in the prostate gland detected by PET/CT.
P2860
Q30309005-80D77D9D-6047-4181-B847-692B46A17510Q30662240-0601352B-DB1D-499B-97A2-F1C9920B81DBQ30698121-0E5C3F4E-25CE-46E9-9408-4EB28DD81393Q30847275-DECD6130-75F3-482D-8346-77DFA0C33C18Q31161889-49588A8C-DA82-44F9-A14B-FF7A44A7215AQ33306300-2500A714-3F31-4A5A-9302-545DC3D9F7E9Q33374241-FEBDF2FF-8A47-4E52-8988-0B67498DA7BBQ33393412-9F4D5004-3816-4562-9A52-2E2C947126EBQ33431458-66EB710D-4D52-4861-B661-E5377F35C741Q33460790-D4EE12B5-3995-45AD-9AB7-4CE9507EB538Q33517492-49A5E8EB-3816-434D-B6F6-0BF3590A9045Q33641704-C1755F7C-E994-4F7B-9554-8C41E7E5FB67Q33705275-86612B15-0A55-4577-B341-43BD9B9182A3Q33716657-E1E29A2E-1E53-4EB8-958D-163562860BCBQ33900727-9247E09D-E8DB-4153-8333-C2214E21B543Q33959412-8CF604EF-FB1A-49A4-B84D-CBA092939BDCQ33996491-922DE717-DDD2-45F6-9446-01589E15FF77Q34133048-D99839AE-123C-4CD1-9DDF-3FD33FA26E8CQ34186121-52AE31E5-41EE-4012-9948-D0D89725283BQ34231678-2C7D08BC-9108-447C-8DA8-A6D6621202E0Q34319541-7BD44C72-92AE-4682-82C0-D69884F9A904Q34340561-5621B4FA-B1B9-4AD1-A29E-53A1FA8747E5Q34394012-76D708E5-6907-4F70-80BD-C078818EF09FQ34493929-47942462-806F-42B4-A3EE-3872EB2E3878Q34523912-F0922FD7-24D8-4D0B-879E-F60F5B85EBFCQ34575573-09E95B35-BF0D-48FF-95F2-EBA122BCB7B0Q34608546-B8DBD645-651C-4623-968D-0AD5761C29B4Q34703693-65DC8641-CC35-4ED5-ABA3-E5D7779C8B46Q34703699-2F724809-AA9C-4BDC-AF78-4148C5657D1AQ34756568-EC28E8BD-5D74-4B60-9F81-BF6CEC02D376Q35072945-AB8CC6A4-303A-43C1-A857-9B4DB9B39739Q35439944-CF3C5595-4BD3-4D26-9595-387946F05930Q35608923-3C1441A2-D7BC-41AF-88FC-C6F005CB27CAQ35784033-12F37EEA-7F39-4518-BF09-0320CBFC86BBQ35867111-AACC2698-A6C5-4854-ADD1-5BBCDF414C23Q35944856-1BC58F47-5D80-49F7-AD06-AA082CF8027CQ35977609-F400E3DA-7C19-4752-B11F-382F155FFCDFQ35998616-74EE21AA-4B00-409E-80AB-15172F6389F3Q36041800-24A0AF10-D01C-4ACA-B8E3-667C3047CF27Q36046171-439319D2-FB8D-4C76-ACC5-939BD77A413E
P2860
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cancer surveillance series: in ...... mortality, and survival rates.
@ast
Cancer surveillance series: in ...... mortality, and survival rates.
@en
type
label
Cancer surveillance series: in ...... mortality, and survival rates.
@ast
Cancer surveillance series: in ...... mortality, and survival rates.
@en
prefLabel
Cancer surveillance series: in ...... mortality, and survival rates.
@ast
Cancer surveillance series: in ...... mortality, and survival rates.
@en
P2093
P356
P1476
Cancer surveillance series: in ...... mortality, and survival rates
@en
P2093
B F Hankey
J M Legler
P C Prorok
R M Merrill
R S Kaplan
P304
P356
10.1093/JNCI/91.12.1017
P407
P577
1999-06-01T00:00:00Z